Long QT syndrome

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 11, 2011, Pages 1272-1275

  Jackson, Heather ^b   Huisman, Lee Anna ^a   Sanatani, Shubhayan ^c   Arbour, Laura T ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Island Medical Program   (Canada)

^c BC CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CASE REPORT; CHILD; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; HEART ARREST; HEART RATE; HUMAN; LONG QT SYNDROME; PRESCHOOL CHILD; QT INTERVAL; RESUSCITATION; SYNCOPE;

EID: 80051575194     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.100138     Document Type: Article

References (9)

1. Arbour L, Rezazadeh S, Eldstrom J, et al. A KCNQ1 V205M missense mutation causes a high rate of long QT syndrome in a First Nations community of northern British Columbia: a community-based approach to understanding the impact. Genet Med 2008;10:545-50.
2. Grunnet M, Behr ER, Calloe K, et al. Functional assessment of compound mutations in the KCNQ1 and KCNH2 genes associated with long QT syndrome. Heart Rhythm 2005;2:1238-49. (Pubitemid 41614170)
3. Goldenberg I, Zareba W, Moss AJ. Long QT syndrome. Curr Probl Cardiol 2008;33:629-94.
4. Schwartz PJ, Stramba-Badiale M, Crotti L, et al. Prevalence of the congenital long-QT syndrome. Circulation 2009;120:1761-7.
5. Gargus JJ. Unravelling monogenic channelopathies and their implications for complex polygenic disease. Am J Hum Genet 2003;72:785-803. (Pubitemid 36403300)
6. Rautaharju PM, Surawicz B, Gettes LS. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram. Part IV: the ST segment, T and U waves, and the QT interval. A scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Circulation 2009;119:e241-50.
7. Vincent GM, Schwartz PJ, Denjoy I, et al. High efficacy of β-blockers in long-QT syndrome type 1 contribution of noncompliance and QT-prolonging drugs to the occurrence of β-blocker treatment "failures." Circulation 2009;119:215-21.
8. Drugs to be avoided by patients with congenital long QT syndrome (CLQTS) [website of the Arizona Center for Education and Research on Therapeutics]. Available: www.azcert.org/medical-pros/drug-lists/CLQTS.cfm (accessed 2010 Jan. 17).
9. Farnsworth MM, Fosyth D, Haglund C, et al. When I go in to wake them ... I wonder: parental perceptions about congenital long QT syndrome. J Am Acad Nurse Pract 2006;18:284-90.